Ryu Yashiro
Overview
Explore the profile of Ryu Yashiro including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
110
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Matsuzaka Y, Yashiro R
Curr Issues Mol Biol
. 2024 Aug;
46(8):8464-8498.
PMID: 39194716
Adeno-associated virus (AAV) is characterized by non-pathogenicity, long-term infection, and broad tropism and is actively developed as a vector virus for gene therapy products. AAV is classified into more than...
2.
Matsuzaka Y, Yashiro R
Pharmaceuticals (Basel)
. 2024 Jun;
17(6).
PMID: 38931374
Mesenchymal stem cells (MSCs) have emerged as a promising approach for drug delivery strategies because of their unique properties. These strategies include stem cell membrane-coated nanoparticles, stem cell-derived extracellular vesicles,...
3.
Matsuzaka Y, Yashiro R
Immunol Invest
. 2024 Mar;
53(1):40-69.
PMID: 38509665
The remarkable diversity of lymphocytes, essential components of the immune system, serves as an ingenious mechanism for maximizing the efficient utilization of limited host defense resources. While cell adhesion molecules,...
4.
Matsuzaka Y, Yashiro R
Vaccines (Basel)
. 2023 Mar;
11(3).
PMID: 36992152
It has been reported that some mutant strains of the new coronavirus escape from neutralizing antibodies acquired by recoverees and vaccine recipients, in which the Omicron strain (B [...].
5.
Matsuzaka Y, Yashiro R
Vaccines (Basel)
. 2023 Mar;
11(3).
PMID: 36992123
Messenger ribonucleic acid (RNA) vaccines are mainly used as SARS-CoV-2 vaccines. Despite several issues concerning storage, stability, effective period, and side effects, viral vector vaccines are widely used for the...
6.
Matsuzaka Y, Yashiro R
Membranes (Basel)
. 2022 Dec;
12(12).
PMID: 36557150
Extracellular vesicles (EV) are membrane vesicles surrounded by a lipid bilayer membrane and include microvesicles, apoptotic bodies, exosomes, and exomeres. Exosome-encapsulated microRNAs (miRNAs) released from cancer cells are involved in...
7.
Matsuzaka Y, Yashiro R
Int J Mol Sci
. 2022 Nov;
23(21).
PMID: 36361760
Extracellular vesicles (EVs), including exosomes, mediate intercellular communication by delivering their contents, such as nucleic acids, proteins, and lipids, to distant target cells. EVs play a role in the progression...
8.
Matsuzaka Y, Yashiro R
Vaccines (Basel)
. 2022 Oct;
10(10).
PMID: 36298556
Extracellular vesicles (EVs) produced by various immune cells, including B and T cells, macrophages, dendritic cells (DCs), natural killer (NK) cells, and mast cells, mediate intercellular communication and have attracted...
9.
Matsuzaka Y, Yashiro R
Int J Mol Sci
. 2022 Jun;
23(12).
PMID: 35742923
Extracellular vesicles (EVs) are lipid bilayer membrane particles that play critical roles in intracellular communication through EV-encapsulated informative content, including proteins, lipids, and nucleic acids. Mesenchymal stem cells (MSCs) are...
10.
Matsuzaka Y, Yashiro R
Membranes (Basel)
. 2022 Jun;
12(6).
PMID: 35736256
Since it has been reported that extracellular vesicles (EVs) carry cargo using cell-to-cell comminication according to various in vivo situations, they are exprected to be applied as new drug-delivery systems...